New Enterprise Associates 16, L.P., 10% Owner at Trevi Therapeutics, Inc. (TRVI), sold 564 shares at $2.66 ($2K) on 2020-04-03, disclosed to the SEC on 2020-04-13.
Open-market sale of $2k TRVI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MTCR | SELL | 2021-12-27 | $649K | — | Filing → |
| RGLS | BUY | 2020-12-07 | $5.5M | — | Filing → |
| AKUS | BUY | 2020-07-01 | $10.0M | — | Filing → |